- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on MET Amplification in New Zealand
Total 136 results
-
Merrimack PharmaceuticalsCompletedHER-2 Gene AmplificationUnited States
-
Kidney Cancer Research BureauRecruitingMetastatic Gastric Cancer | FGFR2 Amplification | PD-L1 Gene AmplificationUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedCCND1 Gene Amplification | CCND2 Gene Amplification | CCND3 Gene Amplification | CDK4 Gene Amplification | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7United States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
Orum Therapeutics USA, Inc.RecruitingHER2-positive Breast Cancer | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionUnited States
-
University of SydneyCompletedOral Health of Older Men | Dietary Assessment of Older MenAustralia
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | FGFR1 Gene Amplification | FGFR2 Gene Amplification | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR1 Gene Mutation | FGFR3 Gene AmplificationUnited States, Canada
-
Andrew CarrCompletedHIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With MenAustralia
-
Chinese University of Hong KongCompletedIntention to Get SARS-CoV-2 Vaccination | Intention to Get SARS-CoV-2 Antibody TestHong Kong
-
Bellicum PharmaceuticalsSuspendedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Solid Tumor, Adult | HER-2 Gene Amplification | HER-2 Protein OverexpressionUnited States
-
Ashwin SomasundaramEMD Serono; University of North Carolina, Chapel HillCompletedGastric Adenocarcinoma | Metastasis | Esophageal Adenocarcinoma | HER-2 Gene AmplificationUnited States
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
Merrimack PharmaceuticalsTerminatedStomach Cancer | Gastroesophageal Junction Cancer | HER-2 Gene Amplification | Esophagus CancerUnited States
-
Syracuse UniversityBoston University; National Institute on Alcohol Abuse and Alcoholism (NIAAA); University of South DakotaCompletedAlcohol Drinking | Men | Sex BehaviorUnited States
-
Yale UniversitySubstance Abuse and Mental Health Services Administration (SAMHSA)CompletedHiv | Pre-Exposure Prophylaxis | MenUnited States
-
Relay Therapeutics, Inc.Active, not recruitingCholangiocarcinoma | Intrahepatic Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Amplification | FGFR2 Gene Fusion/Rearrangement | FGFR2 Gene Translocation | FGFR2 Gene Activation | Other Solid Tumors, AdultUnited States, France, Italy, United Kingdom, Korea, Republic of, Spain, Taiwan, Sweden, Germany, Netherlands, Singapore, Australia, Hong Kong
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Italy, Spain, United Kingdom, Greece, Belgium, Austria, Czechia
-
TakedaCompletedCircadian DysregulationUnited States
-
AbbVieCompletedWet Macular Degeneration | Neovascular Age-related Macular Degeneration | Wet Age-related Macular DegenerationUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung Cancer and MET Exon 14 Skipping MutationUnited States
-
Novartis PharmaceuticalsCompletedNeovascular (Wet) Age-related Macular DegenerationUnited States
-
Far Eastern Memorial HospitalCompleted
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationUnited States
-
Manhattan Eye, Ear & Throat HospitalAlcon ResearchCompletedMaculopathy, Age-RelatedUnited States
-
TyrogenexCompleted
-
Vanda PharmaceuticalsCompletedJet Lag Type InsomniaUnited States
-
Sam Chun Dang Pharm. Co. Ltd.CompletedNeovascular Age-related Macular Degeneration | Wet Age-related Macular DegenerationUnited States, Australia, Bulgaria, Czechia, Hungary, India, Israel, Japan, Korea, Republic of, Latvia, Poland, Russian Federation, Slovakia, Spain
-
BioMed Valley Discoveries, IncTerminatedAdvanced Solid Tumor | MAP2K1 Gene Mutation | BRAF Gene Mutation | MEK Mutation | BRAF Gene Alteration | MEK Alteration | MAP2K1 Gene Alteration | MAP2K2 Gene Mutation | MAP2K2 Gene AlterationUnited States
-
AbbVieRecruitingCNV | AMD | nAMD | Wet AMD | Wet Age-related Macular Degeneration | wAMDUnited States
-
PanOptica, Inc.CompletedNeovascular Age-related Macular DegenerationUnited States, Czechia, United Kingdom, Hungary, Latvia
-
Boehringer IngelheimCompletedWet Macular DegenerationUnited Kingdom, United States, Germany
-
Apellis Pharmaceuticals, Inc.CompletedNeovascular Age-Related Macular DegenerationUnited States, Australia
-
Vitreous -Retina- Macula Consultants of New YorkUnknownNeovascular Age-Related Macular DegenerationUnited States
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompleted
-
AbbVieAbbVieEnrolling by invitationGene Therapy | AMD | nAMD | Wet AMD | Neovascular Age-Related Macular Degeneration (nAMD) | wAMDUnited States
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
Olix Pharmaceuticals, Inc.Trial Runners, LLCRecruitingNeovascular Age-related Macular DegenerationUnited States
-
Regeneron PharmaceuticalsBayerCompletedNeovascular Age-related Macular DegenerationUnited States, Canada
-
BayerCompletedHot Flashes | Healthy Volunteers | Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenGermany
-
SandozCompletedNeovascular Age-related Macular Degeneration (nAMD)United States
-
Genaera CorporationTerminated"Wet" Age-Related Macular DegenerationUnited States
-
Novartis PharmaceuticalsCompletedNeuroendocrine Tumors | Advanced NET of GI Origin | Advanced NET of Lung OriginUnited States, Colombia, Italy, Taiwan, United Kingdom, Belgium, Czechia, Germany, Japan, Saudi Arabia, Canada, Netherlands, Spain, Korea, Republic of, Lebanon, Austria, China, Greece, South Africa, Thailand, Hungary, Turkey, Poland, ... and more
-
SandozCompletedNeovascular Age-related Macular Degeneration (nAMD)United States
-
Helsinn Healthcare SAICON Clinical ResearchRecruitingRET-altered Solid Tumors | RET-altered Non Small Cell Lung CancerUnited States, Japan
-
SunovionCompletedEpilepsy With Partial On-set SeizuresUnited States, Canada
-
Lupin Ltd.RecruitingNeovascular Age-related Macular DegenerationIndia
-
Regeneron PharmaceuticalsBayerCompletedNeovascular (Wet) Age-Related Macular DegenerationUnited States, Puerto Rico
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationUnited States, Puerto Rico
-
Chengdu Kanghong Biotech Co., Ltd.TerminatedNeovascular Age-related Macular DegenerationUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Germany, Hong Kong, Lithuania, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Portugal, Singapore, Spain, Switzerland, Taiwan